CUL4B facilitates HBV replication by promoting HBx stabilization.
Haixia ShanBo WangXiaodong ZhangHui SongXi LiYongxin ZouBaichun JiangHuili HuHao DouChangshun ShaoLifen GaoChunhong MaXiaoyun YangXiaohong LiangYaoqin GongPublished in: Cancer biology & medicine (2021)
CUL4B enhances HBV replication by interacting with HBx and disrupting its ubiquitin-dependent proteasomal degradation. CUL4B may therefore be a potential target for anti-HBV therapy.